Abstract
We determined the antimicrobial susceptibility of 90 clinical isolates of Stenotro-phomonas maltophilia collected in 2009 at a tertiary care hospital in Korea. Trime-thoprim-sulfamethoxazole, minocycline, and levofloxacin were active against most of the isolates tested. Moxifoxacin and tigecycline were also active and hold promise as therapeutic options for S. maltophilia infections.
Original language | English |
---|---|
Pages (from-to) | 439-441 |
Number of pages | 3 |
Journal | Yonsei Medical Journal |
Volume | 53 |
Issue number | 2 |
DOIs | |
State | Published - Mar 2012 |
Keywords
- Antimicrobial susceptibility
- Levofoxacin
- Minocycline
- Stenotrophomonas maltophilia
- Trime-thoprim-sulfamethoxazole